tiprankstipranks
Advertisement
Advertisement
Tenax Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyTenax Therapeutics initiated with an Overweight at Cantor Fitzgerald
1M ago
Tenax Therapeutics price target raised to $34 from $25 at Guggenheim
Premium
The Fly
Tenax Therapeutics price target raised to $34 from $25 at Guggenheim
2M ago
Tenax Therapeutics initiated with an Outperform at LifeSci Capital
Premium
The Fly
Tenax Therapeutics initiated with an Outperform at LifeSci Capital
2M ago
Tenax Therapeutics Advances Phase 3 Study on Levosimendan for PH-HFpEF
PremiumCompany AnnouncementsTenax Therapeutics Advances Phase 3 Study on Levosimendan for PH-HFpEF
4M ago
Tenax Therapeutics reports result of prespecified blinded sample size assessment
Premium
The Fly
Tenax Therapeutics reports result of prespecified blinded sample size assessment
4M ago
Tenax Therapeutics price target raised to $25 from $14 at Guggenheim
Premium
The Fly
Tenax Therapeutics price target raised to $25 from $14 at Guggenheim
4M ago
Tenax Therapeutics Advances Phase 3 Study on Levosimendan for PH-HFpEF
PremiumCompany AnnouncementsTenax Therapeutics Advances Phase 3 Study on Levosimendan for PH-HFpEF
6M ago
Tenax Therapeutics management to meet with Piper Sandler
Premium
The Fly
Tenax Therapeutics management to meet with Piper Sandler
7M ago
Optimistic Buy Rating for Tenax Therapeutics Driven by Strong Patent Portfolio and Market Potential of Levosimendan
Premium
Ratings
Optimistic Buy Rating for Tenax Therapeutics Driven by Strong Patent Portfolio and Market Potential of Levosimendan
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100